147 related articles for article (PubMed ID: 26111043)
21. Comparison of 5-Aminolevulinic Acid Photodynamic Therapy and Clobetasol Propionate in Treatment of Vulvar Lichen Sclerosus.
Shi L; Miao F; Zhang LL; Zhang GL; Wang PR; Ji J; Wang XJ; Huang Z; Wang HW; Wang XL
Acta Derm Venereol; 2016 Jun; 96(5):684-8. PubMed ID: 26775671
[TBL] [Abstract][Full Text] [Related]
22. Testosterone versus clobetasol for maintenance of vulvar lichen sclerosus associated with variable degrees of squamous cell hyperplasia.
Ayhan A; Guven ES; Guven S; Sakinci M; Dogan NU; Kucukali T
Acta Obstet Gynecol Scand; 2007; 86(6):715-9. PubMed ID: 17520405
[TBL] [Abstract][Full Text] [Related]
23. Topical mometasone furoate for vulvar lichen sclerosus.
Cattaneo A; De Magnis A; Botti E; Sonni L; Carli P; Taddei GL
J Reprod Med; 2003 Jun; 48(6):444-8. PubMed ID: 12856516
[TBL] [Abstract][Full Text] [Related]
24. Systematic review and meta-analysis of randomized controlled trials on topical interventions for genital lichen sclerosus.
Chi CC; Kirtschig G; Baldo M; Lewis F; Wang SH; Wojnarowska F
J Am Acad Dermatol; 2012 Aug; 67(2):305-12. PubMed ID: 22483994
[TBL] [Abstract][Full Text] [Related]
25. Management of sexual dysfunction due to vulvar lichen sclerosus in postmenopausal women.
Pinelli S; D'Erme AM; Lotti T
Dermatol Ther; 2013; 26(1):79-82. PubMed ID: 23384025
[TBL] [Abstract][Full Text] [Related]
26. Melanocytic proliferations associated with lichen sclerosus in adolescence.
Bussen SS
Arch Gynecol Obstet; 2009 Dec; 280(6):1039-40. PubMed ID: 19330343
[TBL] [Abstract][Full Text] [Related]
27. Proactive maintenance therapy with a topical corticosteroid for vulvar lichen sclerosus: preliminary results of a randomized study.
Virgili A; Minghetti S; Borghi A; Corazza M
Br J Dermatol; 2013 Jun; 168(6):1316-24. PubMed ID: 23398459
[TBL] [Abstract][Full Text] [Related]
28. Testosterone maintenance therapy. Effects on vulvar lichen sclerosus treated with clobetasol propionate.
Cattaneo A; Carli P; De Marco A; Sonni L; Bracco G; De Magnis A; Taddei GL
J Reprod Med; 1996 Feb; 41(2):99-102. PubMed ID: 8656422
[TBL] [Abstract][Full Text] [Related]
29. The Effect of Lipofilling and Platelet-Rich Plasma on Patients with Moderate-Severe Vulvar Lichen Sclerosus Who were Non-responders to Topical Clobetasol Propionate: A Randomized Pilot Study.
Pensato R; La Padula S
Aesthetic Plast Surg; 2023 Jun; 47(Suppl 1):64-65. PubMed ID: 35641691
[No Abstract] [Full Text] [Related]
30. [Histological illustrated report No. 194. Sclerous and atrophic lichen (Kraurosis) of the vulva].
Grimmer H
Z Haut Geschlechtskr; 1967 Oct; 42(19):Suppl:105-12. PubMed ID: 5597700
[No Abstract] [Full Text] [Related]
31. A case of simultaneously occurring lichen sclerosus and segmental vitiligo: connecting the underlying autoimmune pathogenesis.
Weisberg EL; Le LQ; Cohen JB
Int J Dermatol; 2008 Oct; 47(10):1053-5. PubMed ID: 18986354
[No Abstract] [Full Text] [Related]
32. Letter to the Editor on The Effect of Lipofilling and Platelet-Rich Plasma on Patients with Moderate-Severe Vulvar Lichen Sclerosus who were Non-Responders to Topical Clobetasol Propionate: A Randomized Pilot Study.
Gutierrez-Ontalvilla P; Vidal L; Ruiz-Valls A; Iborra M
Aesthetic Plast Surg; 2023 Jun; 47(Suppl 1):66-68. PubMed ID: 35689103
[No Abstract] [Full Text] [Related]
33. A Survey of Experts Regarding the Treatment of Adult Vulvar Lichen Sclerosus.
Selk A
J Low Genit Tract Dis; 2015 Jul; 19(3):244-7. PubMed ID: 25853633
[TBL] [Abstract][Full Text] [Related]
34. Does longer duration of corticosteroid treatment improve clearance in vulvar lichen sclerosus? Results from a single centre, comparative, open label study.
Corazza M; Toni G; Valpiani G; Morotti C; Borghi A
Dermatol Ther; 2021 Jul; 34(4):e14955. PubMed ID: 33835646
[TBL] [Abstract][Full Text] [Related]
35. Does Clearance of Vulvar Lichen Sclerosus after a Corticosteroid Treatment Correspond to a Decrease in Disease-Related Burden? Results from a Cohort Study Using Pictorial Representation of Illness and Self-Measure and the Dermatology Life Quality Index.
Borghi A; Flacco ME; Zedde P; Toni G; Schettini N; Corazza M
Dermatology; 2023; 239(1):81-90. PubMed ID: 36382657
[TBL] [Abstract][Full Text] [Related]
36. Health-related quality of life and patient-defined benefit of clobetasol 0.05% in women with chronic lichen sclerosus of the vulva.
Schwegler J; Schwarz J; Eulenburg C; Blome C; Ihnen M; Mahner S; Jaenicke F; Augustin M; Woelber L
Dermatology; 2011; 223(2):152-60. PubMed ID: 21997592
[TBL] [Abstract][Full Text] [Related]
37. Nivolumab PD-1 inhibitor immunotherapy associated with vulvar, perineal and perianal lichen sclerosus.
Wernham AGH; Shah F; Velangi S
Clin Exp Dermatol; 2019 Mar; 44(2):e22-e23. PubMed ID: 30430637
[No Abstract] [Full Text] [Related]
38. Open-label trial of cyclosporine for vulvar lichen sclerosus.
Bulbul Baskan E; Turan H; Tunali S; Toker SC; Saricaoglu H
J Am Acad Dermatol; 2007 Aug; 57(2):276-8. PubMed ID: 17442452
[TBL] [Abstract][Full Text] [Related]
39. Association of Topical Corticosteroids With Reduced Vulvar Squamous Cell Carcinoma Recurrence in Patients With Vulvar Lichen Sclerosus.
Chin S; Scurry J; Bradford J; Lee G; Fischer G
JAMA Dermatol; 2020 Jul; 156(7):813-814. PubMed ID: 32374363
[TBL] [Abstract][Full Text] [Related]
40. Treatment of vulvar lichen sclerosus with topical corticosteroids in children: a study of 72 children.
Casey GA; Cooper SM; Powell JJ
Clin Exp Dermatol; 2015 Apr; 40(3):289-92. PubMed ID: 25477189
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
